Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation is a research paper published in Molecular Therapy — Nucleic Acids (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart Lung and Blood Institute
Grant: HL125912
National Heart Lung and Blood Institute
Grant: HL129785
National Heart Lung and Blood Institute
Grant: HL133665
National Heart Lung and Blood Institute
Grant: HL143469
National Heart Lung and Blood Institute
Grant: HL148239
American Heart Association
Grant: 20POST35210967
NHLBI NIH HHS
Grant: R01 HL133665
NHLBI NIH HHS
Grant: R00 HL125912
NHLBI NIH HHS
Grant: K99 HL125912
NHLBI NIH HHS
Grant: R01 HL129785
NHLBI NIH HHS
Grant: R01 HL148239
NHLBI NIH HHS
Grant: R01 HL143469
National Institutes of Health
Grant: 5R01HL129785-03
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction
National Institutes of Health
Grant: 5R01HL143469-03
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery
National Institutes of Health
Grant: 5R01HL133665-03
BET Bromodomain proteins as Novel Epigenetic Targets for prevention of Intimal Hyperplasia after Vascular Surgery
National Institutes of Health
FWCI
0.83
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords